CareFusion, a leading global medical technology company, today announced the completion of its acquisition of the Vital Signs division from GE Healthcare in the U.S., China and certain other geographies.
CareFusion agreed to purchase Vital Signs for $500 million. In connection with this first closing, CareFusion paid GE Healthcare approximately $470 million, funded through cash on hand. The balance of the purchase price will be paid upon completion of the acquisition of the remaining international operations of Vital Signs, pending regulatory review and customary closing conditions.
"The acquisition of Vital Signs doubles the size of our Specialty Disposables business and transforms it into an industry leader by adding global scale and a new call point in anesthesia," said Kieran Gallahue, chairman and CEO of CareFusion. "We are in a better position to serve customers in this large, global and growing market with a broader product portfolio and complementary expertise in respiratory and anesthesia care."
Vital Signs is a leading manufacturer of single-patient-use consumables for respiratory care and anesthesiology, a $3 billion global segment. Vital Signs has annual revenue of approximately $250 million.